Showing 6031-6040 of 9414 results for "".
- FDA Approves Enbrel Biosimilarhttps://practicaldermatology.com/news/fda-approves-enbrel-biosimilar/2458451/The U.S. Food and Drug Administration (FDA) approved Erelzi for multiple inflammatory diseases. Erelzi is a biosimilar to Enbrel (etanercept), which was originally licensed in 1998. The move is no surprise given the unanimous backing of an FDA advisory arm last month. There are now
- Oculus Innovative Sciences Receives FDA Approval for Post-Dermal-Procedures Producthttps://practicaldermatology.com/news/oculus-innovative-sciences-receives-fda-approval-for-post-dermal-procedures-product/2458455/The FDA awarded Oculus Innovative Sciences, Inc. 510(k) clearance for its new post-dermal-procedures product. Under the supervision of a healthcare professional, the product is intended for the removal of foreign material including microogranisms and debris from postdermal procedures. <
- It's So Far, So Good for BioPharmX's New Acne Drughttps://practicaldermatology.com/news/its-so-far-so-good-for-biopharmxs-new-acne-drug/2458458/BioPharmX Corporation’s novel topical minocycline, BPX-01, reduced facial P. acnes by more than 90 percent after four weeks, new research shows. In the Phase 2a study, a daily 10 mg dose of topical minocycline offered P. acnes r
- Face-Aging App May Encourage Sun-Safe Behaviorhttps://practicaldermatology.com/news/face-aging-app-may-encourage-sun-safe-behavior/2458460/Appealing to their vanity may be the best way to encourage young women to practice sun-safe behaviors, a new study shows. The new research, published in
- Fat Chance Teen Acne Doesn't Contain Diacylglycerolshttps://practicaldermatology.com/news/study-fat-chance-teen-acne-doesnt-contain-diacylglycerols/2458462/New research provides a fingerprint of the fats found in sebum, namely diacylglycerols. The findings appear in the Journal of Lipid Resea
- Merz Acquires Aesthetics Medical Device Company ON Light Scienceshttps://practicaldermatology.com/news/merz-acquires-aesthetics-medical-device-company-on-light-sciences/2458463/With its newest acquisition of ON Light Sciences, Inc., Merz North America is expanding their reach into the laser-adjacent dermatologic arena. ON Light Sciences, Inc. is a U.S. medical device company developing technologies to en
- Paratek Initiates Phase 3 Study of Oral Omadacycline for MRSA, Acute Skin Infectionshttps://practicaldermatology.com/news/paratek-initiates-phase-3-study-of-oral-omadacycline-for-mrsa-acute-skin-infections/2458465/The first patient has been dosed in Paratek Pharmaceuticals, Inc.’s second pivotal Phase 3 study of omadacycline for acute bacterial skin and skin structure infections (ABSSSI). Omadacycline is a new once-daily oral and IV, well-tolerated
- Skin Cancer Foundation Calls for Grant Proposals for the 2017 Research Grant Awards Programhttps://practicaldermatology.com/news/skin-cancer-foundation-calls-for-grant-proposals-for-the-2017-research-grant-awards-program/2458466/The Skin Cancer Foundation is calling for grant proposals for their 2017 Research Grant Awards Program. Four grants of $25,000 will be awarded to research projects and clinical studies related t
- Valeant Dermatology ASPIRE HIGHER Scholarship Program Names Winnershttps://practicaldermatology.com/news/valeant-dermatology-aspire-higher-scholarship-program-names-winners/2458472/Valeant Dermatology, a division of Valeant Pharmaceuticals North America LLC, announced the winners of its ASPIRE HIGHER Scholarship Program. Nine undergraduate and graduate students were selected from a pool of 970 applicants and awarded up to $10,000 each tow
- BEVL Blasts Off: New Mobile Network Seeks to Connect Aesthetic Proshttps://practicaldermatology.com/news/bevl-blasts-off-new-mobile-network-seeks-to-connect-aesthetic-pros/2458474/Meet BEVL, a new mobile network that connects medical aesthetics professionals. In private beta testing since June, BEVL is now accessible via iOS, Android and th